Junevity's innovative use of siRNA has sparked interest in the longevity sector. This detailed article from Longevity.Technology explains how co-founder Dr Janine Sengstack and her team target transcription factors to reset aging cells. With promising preclinical data in metabolic diseases, their approach could reshape future therapies and advance our understanding of cellular rejuvenation.